Even when low-priced, generic competition is looming, manufacturers can employ several strategies to extend the commercial potential of their most clinically effective and successful therapies. Xcenda helps manufacturers prepare for generic entrants by reviewing the impact of health policy on specific therapeutic areas, monitoring HTA submission requirements in emerging markets, and offering provider education programs that distinguish leading brands in a crowded marketplace.

Extend commercial opportunities with the following key services:

Conduct meta-analyses

Use real-world data to demonstrate your product's comparative effectiveness and support refined value messages that will defend your product's formulary position as new competitors enter the marketplace.

Read More

Develop a global strategy

Conduct an HTA assessment and evaluate commercial opportunities in new markets. Identify the regulatory, clinical, and health economic evidence required to command market access in emerging and established markets around the world.

Read More

Launch provider field support

Minimize drop-off as generics enter the market by continuing to offer the reimbursement support providers depend on to overcome barriers to access. Distinguish your brand through compliant provider support programs and tools.

Read More